WED-389 Pharmacokinetics and safety of the monoclonal antibody tobevibart (VIR-3434) administered as monotherapy or in combination with the small interfering RNA elebsiran (VIR-2218) in cirrhotic participants with mild hepatic impairment
药代动力学
医学
药理学
单克隆抗体
内科学
抗体
免疫学
作者
Li Wang,Sneha Gupta,Michael A. Chattergoon,Asma El‐Zailik,Cheng Huang,George Hristopoulos,Maribel Reyes